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Prenatal exposure of the female ovine foetus to excess testosterone leads to neuroendocrine dis-
ruptions in adulthood, as demonstrated by defects in responsiveness with respect to the ability of
gonadal steroids to regulate gonadotrophin-releasing hormone (GnRH) secretion. In the ewe,
neurones of the arcuate nucleus (ARC), which co-expresses kisspeptin, neurokinin B (NKB) and
dynorphin (termed KNDy cells), play a key role in steroid feedback control of GnRH and show
altered peptide expression after prenatal testosterone treatment. KNDy cells also co-localise NKB
receptors (NK3R), and it has been proposed that NKB may act as an autoregulatory transmitter in
KNDy cells where it participates in the mechanisms underlying steroid negative-feedback. In addi-
tion, recent evidence suggests that NKB/NK3R signalling may be involved in the positive-feedback
actions of oestradiol leading to the GnRH/luteinising hormone (LH) surge in the ewe. Thus, we
hypothesise that decreased expression of NK3R in KNDy cells may be present in the brains of
prenatal testosterone-treated animals, potentially contributing to reproductive defects. Using sin-
gle- and dual-label immunohistochemistry we found NK3R-positive cells in diverse areas of the
hypothalamus; however, after prenatal testosterone treatment, decreased numbers of NK3R
immunoreactive (-IR) cells were seen only in the ARC. Moreover, dual-label confocal analyses
revealed a significant decrease in the percentage of KNDy cells (using kisspeptin as a marker) that
co-localised NK3R. To investigate how NKB ultimately affects GnRH secretion in the ewe, we
examined GnRH neurones in the preoptic area (POA) and mediobasal hypothalamus (MBH) for
the presence of NK3R. Although, consistent with earlier findings, we found no instances of NK3R
co-localisation in GnRH neurones in either the POA or MBH; in addition, > 70% GnRH neurones
in both areas were contacted by NK3R-IR presynaptic terminals suggesting that, in addition to its
role at KNDy cell bodies, NKB may regulate GnRH neurones by presynaptic actions. In summary,
the finding of decreased NK3R within KNDy cells in prenatal testosterone-treated sheep comple-
ments previous observations of decreased NKB and dynorphin in the same population, and may
contribute to deficits in the feedback control of GnRH/LH secretion in this animal model.
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A candidate afferent signalling system that has received much
recent attention in the central control of gonadotrophin-releasing
hormone (GnRH) secretion is that comprising the tachykinin neu-
rokinin B (NKB) and its high affinity receptor neurokinin-3 (NK3R)
(1,2). Although NKB/NK3R signalling is implicated in diverse physio-
logical functions (3), its importance in modulating gonadotrophin
release was established when human genetic studies revealed that
patients bearing inactivating mutations in the gene encoding NKB
(TAC3) or its receptor NK3R (as encoded by TAC3R) displayed hy-
pogonadotrophic hypogonadism and infertility (4,5). Subsequently, a
growing number of animal studies have established a close associa-
tion between NKB/NK3R signalling and GnRH/luteinising hormone
(LH) secretion in various species, including sheep (6), goat (7), pri-
mate (8) and rat (9). However, the precise neuronal pathway(s) via
which NKB stimulates GnRH secretion are not yet fully determined.
Although a subset of GnRH neurones in the rat have been shown
to co-localise NK3R (10), similar studies in sheep (11) and mice (12)
have failed to reveal NK3R in GnRH neurones, suggesting that the
action of NKB upon GnRH secretion is likely exerted via inputs from
other neurones, either directly or indirectly.
The neuroanatomical location of NK3R has been described previ-
ously in the ewe and includes NK3R-immunoreactive (-IR) cells in a
variety of preoptic and hypothalamic nuclei, including the preoptic
area (POA), retrochiasmatic area (RCh) and arcuate nucleus (ARC)
(11). In the ARC, NKB is co-localised with two other neuropeptides,
kisspeptin and dynorphin, in a population that is termed KNDy
(kisspeptin, neurokinin B and dynorphin) cells (13). KNDy cells are
present in the ARC of all species studied to date (14) and are con-
sidered to play a key role in the negative-feedback effects of oes-
tradiol and progesterone upon GnRH (14). In addition, KNDy cells
are considered to comprise a critical component of the circuitry
responsible for the generation of GnRH/LH pulses (7,9,16). Accumu-
lating evidence suggests that NKB acts as an auto-regulatory signal
within the network of reciprocally interconnected KNDY cells, com-
prising a signal that is responsible for the initiation of each GnRH
pulse (16).
In addition to its role in negative-feedback, in the sheep, NKB/
NK3R signalling may also be important in the generation of the
preovulatory GnRH/LH surge (13,17–19). Intracerebroventricular
microinjections of senktide, a NK3R specific agonist (2), results in a
surge-like elevation of LH during the follicular but not the luteal
phase of the ovine oestrous cycle (6). Bilateral senktide microinjec-
tions into the RCh (6) and POA (20) are each able to produce a
similar surge-like elevation of LH, suggesting that these two areas,
each of which contain NK3R-positive cells, may participate in the
control of the LH surge. In addition, there are several lines of evi-
dence suggesting that KNDy cells may participate in the GnRH/LH
surge in the ewe (18,19,21–24). For example, in the sheep (17),
unlike rodents (25), oestradiol implants in the mediobasal hypothal-
amus, close to the vicinity of KNDy cells, are sufficient to induce a
GnRH/LH surge. Thus, NKB/NK3R signalling could potentially play a
role in both the negative- and positive-feedback effects of gonadal
steroids in the sheep, acting at potential target sites that include
the POA, RCh and KNDy cells of the ARC.
The responsiveness of the adult GnRH system to hormonal feed-
back controls is programmed during development by events that
include foetal exposure to androgens (26,27). Although normal sex-
ual differentiation depends on appropriate timing of exposure of
foetuses to androgens, exposure to excess androgens in animal
models can result in long-term deficits in reproductive functions
at multiple levels, including the GnRH system (28). For example,
exposure of female ovine foetuses to excess testosterone during
days 30–90 of the 147-day gestation, leads to neuroendocrine
defects in the responsiveness of the GnRH system to both nega-
tive and positive steroid feedback (29–32). KNDy neurones have
been implicated as critical mediators of the detrimental effects of
prenatal testosterone (33), and prenatal testosterone treatment
results in dramatic alterations in KNDy peptides in the adult ARC,
with NKB and dynorphin being markedly reduced but kisspeptin
remaining unaltered. This peptide imbalance within a single neuro-
nal population has been hypothesised to underlie some of the
defects in responsiveness of the GnRH system to oestradiol and
progesterone seen in adult female sheep exposed prenatally to
excess testosterone (33).
Whether postsynaptic receptors for any of the KNDy peptides
are similarly altered in prenatal testosterone-treated animals has
not yet been examined and, given the evidence for participation
of NKB/NK3R signalling in both pulsatile and surge modes of
GnRH/LH secretion, we hypothesised that changes in NK3R
expression in either the ARC or in other regions where it has
been shown to alter LH secretion (e.g. RCh, POA) may be present
in the brains of prenatal testosterone-treated female sheep. To
test this hypothesis, we first compared the overall number of
NK3R-IR cells in the ARC, RCh, POA and other hypothalamic
nuclei between prenatal testosterone-treated and control animals.
Second, we used dual-label immunofluorescence and confocal
microscopy to determine whether NK3R might be specifically
altered within the KNDy cell subpopulation of the ARC. Finally,
because NK3R-IR is seen in fibre and terminals, as well as cell
bodies, we explored the possibility that NKB might act presynapti-
cally to influence GnRH secretion by determining whether NK3R-
IR terminals in the POA and medial basal hypothalamus (MBH)
are in direct synaptic contact with GnRH cell bodies in those
regions. To control for the possible influence of differences in cir-
culating steroids between the experimental and control groups,
animals were ovariectomised prior to sacrifice and implanted with
hormonal regimens designed to produce late follicular phase con-
centrations of oestradiol.
Materials and methods
Animal care and treatment
All procedures involving animals were approved by the University of Michi-
gan Animal Care and Use Committee and are consistent with National
Research Council’s Guide for the Care and Use of Laboratory Animals. The
experiments were conducted in 2-year-old control and prenatal testoster-
one-treated Suffolk ewes during the breeding season. Housing, breeding,
lambing and maintenance took place at the Sheep Research Facility at the
University of Michigan (Ann Arbor, MI, USA; 42°180 north latitude) as
described previously (34,35).
Pregnant ewes were administered i.m. injections of testosterone propio-
nate (100 mg/injection catalog item T1875; Sigma-Aldrich, St Louis, MO,
USA; n = 8) twice weekly, suspended in cottonseed oil (catalogue number
C7767; Sigma-Aldrich) in the hind leg from days 30 to 90 of pregnancy
(term = 147 days). The dose of testosterone propionate administered results
in levels of testosterone in the female foetus comparable to those in foetal
males (36). Control ewes received an equal volume of vehicle (2 ml cotton-
seed oil; n = 9) with the same regimen as testosterone. Lambs were born in
March/April. After weaning, they were maintained outdoors under natural
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photoperiods with a daily maintenance feeding and free access to water.
During the first breeding season, progesterone profiles and ultrasonographic
assessment of ovarian status was carried out (37). In addition, at approxi-
mately 19 months of age, all ewes were ovariectomised and evaluated for
LH surge and sexual behaviour profiles (38). For the present study, and to
normalise the hormonal milieu between all animals, a 1-cm long Silastic
capsule (inner diameter 3.35 mm; outer diameter 4.65 mm; Dow Corning
Corp., Midland, MI, USA) filled with 17b oestradiol (oestradiol; Sigma-
Aldrich) and two controlled internal drug release (CIDR) progesterone
implants (InterAG, Hamilton, Waikato, New Zealand) were inserted s.c. into
each animal. CIDRS were removed 14 days later and, sequentially, all ani-
mals received additional four 3-cm long oestradiol implants (see above) to
simulate ovarian steroid levels equivalent to a normal follicular phase, as
well as to generate a GnRH/LH surge (41). Animals were euthanised approxi-
mately 20 h after insertion of the oestradiol implants and specifically during
the late follicular phase (i.e. prior to the LH surge in both control or testos-
terone-treated animals) (38). The oestradiol implant insertion and euthanasia
where staggered at hourly intervals to allow for the time needed to perfuse
and extract the brain.
Tissue collection and preparation
Ewes were injected i.v. twice at 10-min intervals with 25 000 U of
heparin (catalogue number 402588B; Abraxiz Pharmaceutical Products,
Schaumburg, IL, USA) and then deeply anaesthetised with i.v. sodium pen-
tobarbital (2–3 g; catalogue number P3761; Sigma-Aldrich). Animals were
rapidly decapitated, and the heads perfused via both internal carotids with
6 litres of 4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.3)
mixed with 0.1% sodium nitrite and administered with 10 U/ml heparin.
After perfusion, the brain was removed and a tissue block containing the
septal region, POA and hypothalamus dissected out. Blocks were incubated
in 4% paraformaldehyde at 4 °C overnight for post-fixation and then
transferred into 30% sucrose in 0.1 M PB for cryoprotection until infiltra-
tion took place. A sliding freezing microtome (SM 200R; Leica Biosystems,
Walldorf, Germany) was used to section frozen blocks of tissue containing
POA and hypothalamus into six series of coronal 45-lm slices. Free-float-
ing sections were stored in cryoprotectant solution (30% ethylene glycol,
1% polyvinylpyrrolidone, 30% sucrose in sodium phosphate buffer) (42) at
20 °C until processed for immunohistochemistry. Within each experi-
ment, tissue sections from all experimental groups were processed simul-
taneously as described below. All immunohistochemical procedures were
carried out at room temperature under gentle agitation. Unless otherwise
stated, tissue sections were washed with 0.1 M phosphate-buffered saline
(PBS; pH 7.2) between steps. Antibodies were diluted with blocking
solution, comprising 0.4% Triton X-100 (catalogue number BP151-500;
Sigma-Aldrich) and 4% normal goat serum (NGS; catalogue number
H005-000-121; Jackson ImmunoResearch Laboratories, West Grove, PA,
USA) in 0.1 M PBS.
Experiment 1: Effects of prenatal testosterone-treatment
on NK3R-IR in the POA and hypothalamus
Single-label immunohistochemistry for NK3R
The distribution and quantification of NK3R-IR cells was determined in a
series of every sixth section (270 lm apart). Free-floating sections were
washed thoroughly in 0.1 M PBS for several hours to remove excess cryo-
protectant, followed by a 10-min incubation with PBS containing 1%
hydrogen peroxide (H2O2; catalogue number H325; Fisher Scientific, Pitts-
burgh, PA, USA) to eliminate endogenous peroxidase activity. Next, sec-
tions were incubated in blocking solution for 1 h followed by an
overnight (17 h) incubation with polyclonal rabbit anti-NK3R (dilution
1 : 10 000; catalogue number NB300-102; Novus Biological, Littleton, CO,
USA). After incubation with the primary antiserum, sections were incu-
bated with biotinylated goat anti-rabbit immunoglobulin G (dilution
1 : 500; catalogue number BA-1000; Vector Laboratories, Burlingame, CA,
USA) for 1 h followed by incubation with ABC reagent (dilution 1 : 500
diluted in 0.1 M PBS; avidin and biotinylated horseradish peroxidase mac-
romolecular complex, catalogue number PK-6100; Vector Laboratories) for
1 h. NK3R labelling was visualised using 3,30-diaminobenzidine tetrahydro-
chloride (0.2 mg/ml) (catalogue number D5905; Sigma-Aldrich) with
0.00004% hydrogen peroxide in PB as substrate. Finally, they were
mounted onto Superfrost/Plus Microscope Slides (Fisher Scientific), air-dried
and coverslipped with DPX Mountant. Omission of NK3R antibody from
the immunohistochemical protocol resulted in complete absence of stain-
ing. Furthermore, preabsorption controls with purified antigen have been
performed and described previously (see below) (11).
Experiment 2: Effects of prenatal testosterone-treatment
on NK3R-IR within the POA kisspeptin and ARC KNDy cell
population
Dual-label immunofluorescent detection of NK3R and
kisspeptin
To determine whether changes in NK3R-IR occurred specifically within the
POA kisspeptin or ARC KNDy cell population, an alternate series of every
sixth section (270 lm apart) containing the POA or ARC was processed
for dual-label immunofluorescence and confocal microscopic analysis. A
modification of the protocol reported by Hunyady et al. (43) was carried
out to eliminate possible cross-linking between kisspeptin and NK3R anti-
bodies (both raised in rabbits) and false co-localisation between antigens.
Initially, free-floating tissue sections were washed several hours in PBS
for cryoprotectant removal. Subsequently, they were incubated in PBS
containing 1% H2O2 for 10 min followed by a 1-h incubation in blocking
solution (with 20% NGS). Next, rabbit polyclonal anti-NK3R (dilution
1 : 10 000 for 17 h) was applied. Sections were then incubated sequen-
tially in biotinylated goat anti-rabbit (dilution 1 : 500 for 1 h) and ABC-
elite solution (dilution 1 : 500 diluted in 0.1 M PBS for 1 h). After amplifi-
cation with TSA Biotin system Biotinyl Tyramide agent (dilution 1 : 250
diluted in 0.1 M PBS with 3% H2O2; catalogue number NEL700A001KT;
PerkinElmer Life Sciences, Waltham, MA, USA), NK3R was visualised with
Alexa 488 conjugated streptavidin (dilution 1 : 100 diluted in 0.1 M PBS
for 30 min; catalogue number S-32354; Invitrogen/Molecular Probes,
Eugene, OR, USA). Sections were then processed for detection of kisspep-
tin. First, they were incubated for 17 h with primary antibody rabbit anti-
kisspeptin (a gift from A. Caraty, Universite Tours, Nouzilly, France; lot
number 564) at a dilution of 1 : 2000 (for POA sections) or 1 : 10 000
(for ARC sections) and visualised with goat anti-rabbit Alexa 555 (dilution
1 : 100 in 0.1 M PBS for 30 min; catalogue number A-21428; Invitrogen/
Molecular Probes). Finally, sections were mounted on glass slides, dried
and coverslipped with mount medium gelvatol. Control sections for the
dual immunofluorescent procedure included the omission of each of the
primary antibodies from the immunostaining protocol, which resulted in a
complete absence of staining for the corresponding antigen. In addition,
pre-absorption controls have been performed for each of the antibodies
in previous studies (11); in each case, pre-incubation of the diluted anti-
serum with nanomolar concentrations of purified antigen was shown to
be sufficient to eliminate all specific staining in ewe hypothalamic sec-
tions. Finally, the kisspeptin antibody used has been shown to be specific
for kisspeptin cells of the ovine brain and not to cross-react with other
RFamide peptides (44).
© 2014 British Society for Neuroendocrinology Journal of Neuroendocrinology, 2015, 27, 100–110
102 T. Ahn et al.
Experiment 3: Identification of pre-synaptic NK3R terminals
onto GnRH neurones in the POA and MBH
Triple-label immunofluorescent detection of GnRH, NK3R
and synaptophysin
A series of every 12th section (540 lm apart) through the POA and MBH
were used for GnRH/NK3R/synaptophysin triple labelling. Similar to the pro-
tocols described above, free-floating sections were washed in 0.1 M PBS for
several hours to remove cryoprotectant. Next, they were incubated in 1%
H2O2 diluted in PBS for 10 min, followed by a 1-h incubation in blocking
solution (with 20% NGS). Subsequently, sections were incubated sequentially
in rabbit polyclonal anti-NK3R, biotinylated goat anti-rabbit, ABC-elite solu-
tion and TSA Biotin system Biotinyl Tyramide agent, as described above.
NK3R was visualised with Alexa 488 conjugated streptavidin (dilution
1 : 100 in 0.1 M PBS for 30 min). The second primary antibody, rabbit anti-
GnRH (dilution 1 : 1000; LR-5, a gift from R. Benoit, Montreal General Hos-
pital, Montreal, Canada), was visualised using indirect detection with goat
anti-rabbit Alexa 555 (dilution 1 : 100 in 0.1 M PBS; catalogue number
S-32354; Invitrogen/Molecular Probes). During the GnRH antibody incuba-
tion period, mouse anti-synaptophysin (dilution 1 : 200; catalogue number
S5768; Sigma-Aldrich) was also co-incubated and visualised with donkey
anti-mouse Cy5 (dilution 1 : 100 in 0.1 M PBS for 30 min; Catalogue num-
ber 715175151; Jackson ImmunoResearch Laboratories). Controls omitting
one, two or all three primary antisera from the protocol completely elimi-
nated all specific staining for the corresponding antigen(s).
Data analysis
For single-label NK3R, the distribution of IR cells and fibres was examined
in sections through the POA and hypothalamus of each ewe. Three repre-
sentative sections of the rostral, middle and caudal divisions of the ARC,
RCh, ventral portion premammillary nucleus, POA, lateral hypothalamic area
and paraventricular nucleus were quantitatively analysed per animal in each
group. Each nucleus was determined by its cytoarchitectonic boundaries and
all cells within those boundaries were quantified. Areas chosen for analysis
were based on the regional distribution of NK3R-IR cells previously
described in the ewe (11). The ARC, which contains prominent NK3R-IR, was
divided into three rostral–caudal divisions for more detailed analysis in the
present study as described previously (11,45). Our preliminary observations
revealed that the rostral ARC contained very few NK3R-IR cells and fibres
compared to the middle and the caudal ARC. Moreover, given that a large
majority of KNDy cells are found in the middle and caudal divisions (45,46),
we selected these subregions for detailed comparison between control and
prenatal testosterone-treated animals.
For single-label analyses (Experiment 1), NK3R-IR cells were examined
and quantified with a DMRD microscope (Leica Microsystems GmbH, Wetz-
lar, Germany) and identified by the presence of dense reaction product that
labelled their somas and dendrites. Images were captured using a digital
camera (Magnafire; Optronics, Goleta, CA, USA) attached to the microscope
and imported into PHOTOSHOP, version 7.0 (Adobe Systems, San Jose, CA, USA).
Photomicrographs were not altered in any way, except for minor adjust-
ments of brightness and contrast.
Sections processed for dual and triple immunofluorescence were analysed
using a Zeiss LSM-510 laser-scanning confocal microscope system (Zeiss,
Thronwood, NY, USA). Alexa 488 fluorescence was visualised and imaged
with a 505–530-nm emission filter and argon laser, whereas Alexa 555 and
CY5 fluorescence with a 560-nm and 680-nm emission filter and a HeNe
laser. Confocal Z-stacks of optical sections (1 lm at 9 63 magnification)
were captured through NK3R, kisspeptin and GnRH-IR neurones. Three
Z-stacks from the middle and caudal ARC of each animal were used for
analysis of NK3R/kisspeptin co-localisation. A total of 700 kisspeptin-IR cells
from the middle ARC and 692 cells from the caudal ARC (between 38 and
42 kisspeptin-IR cells per treatment group and ARC subdivision) were analy-
sed. For examination of possible co-localisation in the POA, a total of 42
kisspeptin-IR cells from three control animals (between 12 and 16 kisspep-
tin-IR cells per animal) were analysed.
For analysis of GnRH/NK3R/synaptophysin material, six to 10 Z-stacks
were captured from the POA and ARC to obtain sufficient number of GnRH-
IR neurones for analysis. Putative contacts between NK3R/synaptophysin-
positive terminals and GnRH-IR somas were defined as a direct apposition
without any intervening (black) pixels. A total 49 POA GnRH neurones and
34 MBH GnRH neurones were analysed from five random control animals
(between seven and 12 POA and six or seven MBH GnRH neurones per ani-
mal). First, the somal perimetre was calculated by tracing the neurone. Sub-
sequently, in each Z-stack of 1-lm optical section, the number of NK3R-
positive terminals in direct contact with the GnRH neurone was determined.
The percentage of GnRH neurones in the POA and MBH having one or more
NK3R-positive contacts was calculated, as was the mean number of NK3R-
positive contacts onto GnRH somas per animal, and the mean number of
contacts per 10 lm of GnRH somal perimeter.
Statistical analysis
All data are expressed as the mean  SEM. Statistical comparisons between
control and prenatal testosterone-treated ewes (Experiments 1 and 2) and
between brain regions (Experiment 3) were made using Student’s t-test. All
statistics were performed using SIGMASTAT windows (SPSS Inc., Chicago, IL,
USA). P < 0.05 was considered statistically significant.
Results
Experiment 1: Effects of prenatal testosterone-treatment
on NK3R-IR cell numbers in the POA and hypothalamus
NK3R-IR cells were present in a number of areas of the hypothala-
mus in addition to the ARC (Fig. 1). The most prominent and dense
populations of NK3R-IR neurones, other than the ARC, were
observed (in descending order of overall cell number) in the hypo-
thalamic paraventricular nucleus, lateral hypothalamic area, ventral
premammillary nucleus, RCh and POA. In the ARC, where KNDY
cells reside, we confirmed a large number of NK3R-IR cells, specifi-
cally in the middle and caudal divisions of this nucleus (Fig. 1).
Quantitative cell counts revealed that the mean number of
NK3R-IR cells observed in the ARC of control ewes was significantly
greater than that of prenatal testosterone-treated animals in both
the middle (control: 53.8  2.9 versus prenatal testosterone:
41.6  2.8; P = 0.009) and caudal portions (control: 42.7  4.0
versus prenatal testosterone: 30.0  2.5; P = 0.019; Fig. 2) of this
nucleus. No significant differences in NK3R-IR cell number between
control and prenatal testosterone-treated animals were observed in
any of the other nuclei or areas analysed (Fig. 2).
Experiment 2: Effect of prenatal testosterine-treatment on
NK3R-IR co-localisation within the ARC KNDy cell
population
To determine whether changes in NK3R-IR cell number observed
in the ARC, reflect a change in NK3R specifically in the KNDy cell
© 2014 British Society for NeuroendocrinologyJournal of Neuroendocrinology, 2015, 27, 100–110
Prenatal testosterone decreases NK3R immunoreactivity in the ARC 103
population, we analysed sections processed for dual-immunofluores-
cent localisation of NK3R and kisspeptin (Kiss). Prenatal testosterone-
treated animals showed a decrease in the number of dual-labelled
NK3R/Kiss cells (control: 19.4  1.7 versus prenatal testosterone:
14.4  1.2; P = 0.049; Fig. 3G), as well as the total number (single-
labelled + dual-labelled) of ARC NK3R-IR cells (control: 25.9  2.1
versus prenatal testosterone: 20.7  1.7; P = 0.021; Fig. 3G). As in
previous studies (33), we saw no difference between control and pre-
natal testosterone animals in the total number of Kiss cells (Fig. 3G)
and, consistent with the decrease in number of dual NK3R/Kiss cells,
the number of single-labelled Kiss cells was significantly higher in
prenatal testosterone ewes (control: 21.5  1.6 versus prenatal tes-
tosterone: 26.7  1.4; P = 0.038; Fig. 3G).
We used the numbers of dual-labelled and total cells in individ-
ual animals to calculate the percentage of ARC Kiss-IR cells co-
localising NK3R and, conversely, the percentage of NK3R-IR
neurones co-localising Kiss. The mean percentage of Kiss-IR neuro-
nes co-localising NK3R was significantly decreased in prenatal
testosterone animals compared to controls (control: 47.1  3.0%
versus prenatal testosterone: 34.7  2.4%; P = 0.005; Fig. 3H). By
contrast, there was no significant difference between control and
prenatal testosterone-treated animals in the percentage of NK3R-IR
neurones co-localising Kiss (Fig. 3H).
Because NK3R-IR cells are present in the POA (Figs 1 and 2), we
also examined kisspeptin cells in the ovine POA for co-localisation
of NK3R. However, the kisspeptin/NK3R co-localisation in the POA
was infrequent and variable (mean  SEM: 5.3  5.3%) such that
further comparison with prenatal testosterone-treated animals was
not pursued.
Experiment 3: Co-localisation of NK3R-IR in presynaptic
terminals contacting GnRH neurones
In addition to detecting NK3R-IR in cell bodies (Experiment 1), we
also noted NK3R localisation in fibres and terminals throughout a
number of hypothalamic regions, including the POA and MBH.
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Fig. 1. Schematic drawings of coronal sections through the ovine preoptic area (POA) and hypothalamus, depicting the distribution of neurokinin-3 receptor-
immunoreactive (NK3R-IR) cells. Each solid circle represents approximately 10 NK3R-IR cells. (A) BNST, bed nucleus of stria terminalis; GP, globus pallidus; ac,
anterior commissure; SON, superior optic nucleus; OVLT, organum vasculosum of lamina terminalis; SI, substantia innominata; OC, optic chiasm; (B) fx, fornix;
PVN, paraventricular nucleus; 3V, third ventricle; IC, internal capsule; AHA, anterior hypothalamic area; OT, optic tract; LHA, lateral hypothalamic area; (C) RCh,
retrochiasmatic area; (D) ZI, zona incerta; mt, mammillary tract; mARC, middle arcuate; (E) CP, cerebral peduncle; PMv, premammillary ventricle; cARC, caudal
arcuate; mr, mammillary recess.
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Consequently, we processed sections for triple-label detection of
NK3R, GnRH and synaptophysin to determine whether any of these
NK3R-positive terminals were directly presynaptic to GnRH cell
bodies in either the POA or MBH. Examination of triple-labelled sec-
tions showed that, from a total of 83 GnRH cells analysed (49 in
the POA; 34 in the MBH), none contained NK3R, confirming our
earlier results showing the lack of co-localisation of NK3R in ovine
GnRH cells (11). However, NK3R-positive fibres were observed adja-
cent to, and intermixed with, GnRH cells and dendrites in both the
POA and MBH. We found that > 70% of GnRH neurones examined
were contacted by one or more NK3R-IR presynaptic bouton
(defined by the co-localisation of synaptophysin; Fig. 4 and
Table 1). Neither the percentage of GnRH cells receiving inputs, nor
the mean number of inputs varied regionally between the POA and
MBH (Table 1). Similarly, the mean number of contacts per 10-lm
GnRH somal perimeter did not differ between the POA and MBH
(Table 1).
Discussion
Our results indicate that prenatal testosterone-treated ewes showed
significantly diminished numbers of NK3R-IR neurones in the ARC
compared to control animals. Furthermore, the decrease in NK3R
was primarily a result of changes within the KNDy cell population
and not in other ARC cells because the number of single-labelled
NK3R-IR cells (i.e. NK3R cells outside the KNDy cell population) in
this region showed no difference between control and prenatal tes-
tosterone animals. The reduced number of NK3R-IR cells observed
in prenatal testosterone female sheep parallels the decrease in
numbers of NKB cells previously observed in this animal model (33)
and suggests that the combined decrease in both ligand and recep-
tor may contribute to defects in the control of GnRH/LH secretion.
Two possible functional consequences may be envisaged. One
rests upon the proposed role of NKB/NK3R signalling in the genera-
tion of GnRH pulses (13). In the current model of GnRH pulse gen-
eration in ruminants (47), NKB serves as a ‘start signal’ that is
responsible for initiation of each GnRH pulse and, by way of reci-
procal connections, activates other NK3R-containing KNDy cells and
ultimately GnRH neurones. Conceivably, decreased NKB and NK3R
would lead to a diminished ability to initiate GnRH pulses and
hence a decrease in GnRH/LH pulse frequency. However, prenatal
testosterone animals show the opposite: an increase in LH pulse
frequency in gonadal-intact ewes during anoestrus and the luteal
phase of the oestrous cycle as a result of decreased responsiveness
to the negative-feedback influence of oestradiol and progesterone,
respectively (31,33,40). However, in addition to NKB, dynorphin pep-
tide expression is also reduced in the KNDy cells of prenatal testos-
terone sheep (33). Evidence in ruminants supports the role of
dynorphin in KNDy cells as a ‘stop’ signal, terminating each GnRH/
LH pulse (16). Hence, it is possible that reductions in dynorphin
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Fig. 2. (A) Mean  SEM number of neurokinin-3 receptor-immunoreactive (NK3R-IR) cells/hemisection in the preoptic area (POA), paraventricular nucleus
(PVN), retrochiasmatic area (RCh), lateral hypothalamic area (LHA) and premammillary ventricle (PMv) of control (n = 9) and prenatal testosterone (T)-treated
(n = 8) groups. There were no statistically significant differences between control and prenatal testosterone-treated ewes in these areas. (B) Mean  SEM
number of NK3R immunoreactive cells/hemisection in the middle and caudal arcuate nucleus (ARC) from control (n = 9) and prenatal testosterone-treated
(n = 8) groups. *Statistically significant differences within each subdivision compared to controls (P < 0.05). (C–F) Representative images showing examples of
NK3R-IR cells (arrows) in the ARC of control (C, middle ARC; D, caudal ARC) and prenatal testosterone-treated ewes (E; middle ARC; F, caudal ARC). Scale
bar = 50 lm.
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signalling compensate for that of NKB and NK3R, rendering the
KNDy network less responsive to the negative-feedback influence of
oestradiol and progesterone in prenatal testosterone animals. None-
theless, although KNDy cells are known to be potential targets for
direct actions of oestradiol and progesterone (13), we do not know
whether these gonadal hormones inhibit GnRH/LH pulse frequency
by acting directly on KNDy cells or indirectly via afferents from
other cells. Evidence from KNDy cell-ablated rats suggests that,
although KNDy cells participate in the negative-feedback influence
of oestradiol on LH, other non-KNDy cells and pathways may also
play a role (48). Similarly, despite the importance of NKB signalling
on kisspeptin and hence GnRH stimulation, recent reports indicate
that prenatal dihydrotestosterone treatment of peripubertal rats
leads to elevated LH responses to i.c.v. kisspeptin administration
(49). This, once again, is in accordance with decreased dynorphin
expression rather than a reduction in NKB/NK3R signalling.
Another possibility is that decreased NKB/NK3R in prenatal tes-
tosterone sheep is related to deficits in the amplitude of the LH
surge as seen in these animals (28,39). KNDy cells in the sheep
express Fos, a marker of neuronal activation, during the preovulatory
LH surge (19,24,18); i.c.v. injections of senktide, which elicit a surge-
like elevation in LH, also induce Fos in ARC KNDy cells (20).
Although kisspeptin mRNA and peptide expression in KNDy cells is
increased during the late follicular phase in the ewe (21,22), an oes-
tradiol stimulus that induced an LH surge was unable to increase in
mRNA levels for NKB in the ARC (46). In addition, although NKB
agonist injections locally into the POA and RCh, such as i.c.v. injec-
tions, result in a prolonged surge-like elevation of LH (see below),
senktide injections in the ARC cause only a modest increase in LH
(20) consistent with the role of NK3R in pulse generation in this
region. Nonetheless, the possibility that NK3R signalling in KNDy
cells plays a role in the generation of the LH surge in the ewe needs
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Fig. 3. (A–F) Confocal images (1-lm optical sections) showing dual-label immunofluorescent detection of neurokinin-3 receptor-immunoreactive (NK3R-IR)
and kisspeptin-IR in the middle arcuate nucleus (ARC) of control (A–C) and prenatal testosterone (T)-treated ewes (D–F). Arrows indicate examples of dual-
labelled neurones. Scale bar = 20 lm (9 63). (G) Mean  SEM number of single-labelled NK3R, single-labelled kisspeptin (Kiss), dual-labelled NK3R and kiss-
peptin (NK3R/Kiss), and total kisspeptin and NK3R-IR neurones in the ARC of control (n = 9) and prenatal testosterone-treated (n = 8) ewes. (H) Mean  SEM
percentage of kisspeptin cells co-localising NK3R (%Kiss/NK3R; left) and percentage of NK3R cells co-localising kisspeptin (%NK3R/Kiss; right) in the ARC of
control (n = 9) and prenatal testosterone-treated (n = 8) groups. *Statistically significant difference compared to controls (P < 0.05).
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to be tested directly by NK3R antagonist injections into the ARC in
follicular phase ewes. By contrast to the reduction in NK3R-IR cells
that we observed in the ARC, no changes were seen in the POA or
in any other hypothalamic nuclei analysed in the present study. We
were particularly surprised by the absence of any changes in the
POA and RCh because senktide microinjections into either region are
able to elicit a surge-like pattern of LH release (20) similar to that
seen after i.c.v. injections of this agonist (6). Microimplants contain-
ing NKB antagonist (SB222200) into the RCh but not the POA
reduce the amplitude of the LH surge by 40%, suggesting that NKB
release in the RCh during the follicular phase is physiologically
important to the generation of the LH surge (20). Because i.c.v.
injections of kisspeptin antagonists in follicular phase ewes only
reduce surge amplitude by 50% (22), it is tempting to speculate that
NKB and kisspeptin act synergistically to elevate LH release during
the surge. Interestingly, tract tracing data demonstrate that KNDy
neurones receive direct input from neurones in the RCh (50) and
administration of senktide into the RCh induces c-Fos expression in
the ARC population (20). Taken together, these findings suggest that
NKB signalling in the RCh plays a role in the preovulatory LH surge,
and that the effect of NKB in the RCh is likely mediated, at least in
part, by projections to ARC KNDy neurones. We are currently investi-
gating the existence of reciprocal connection from the ARC to the
RCh, constituting a potential pathway via which NKB/NK3R and
kisspeptin/Kiss1r signalling are involved in the GnRH surge mecha-
nism. If NKB/NK3R in KNDy cells contribute to this mechanism, then
NK3R GnRH
MergedSyn
Fig. 4. Triple-label detection of neurokinin-3 receptor (NK3R), gonadotrophin-releasing hormone (GnRH) and synaptophysin (Syn) in a 1-lm confocal optical
section, demonstrating the presence of presynaptic NK3R-immunoreactive terminals in contact with GnRH neurones in the mediobasal hypothalamus. Scale
bar = 10 lm.
Table 1. Presynaptic Neurokinin-3 Receptor (NK3R) Terminals in Contact
with Gonadotrophin-Releasing Hormone (GnRH) Somas: Mean  SEM Per-
centage of GnRH Neurones Receiving One or More NK3R-Immunoreactive
(-IR) Contact, Mean Number of NK3R-IR Contacts per GnRH Soma, and
Mean Number of NK3R-IR Contacts per 10 lm Cell Surface, for GnRH Cells
in the Pre-Optic Area (POA) and Mediobasal Hypothalamus (MBH) of Control
Ewes (n = 5).
GnRH cell bodies POA MBH P
Percentage of somas
receiving one or
more NK3R contacts
71.3  8.1 79.1  7.6 0.508
Total number of NK3R
contacts/soma/animal
3.0  0.6 4.8  1.0 0.158
Mean number of NK3R
contacts/10-lm
somal perimeter
0.5  0.2 0.8  0.1 0.189
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administration of the NKB agonist, senktide, should, at least partially
reverse the defects in GnRH surge amplitude seen in prenatal tes-
tosterone-treated ewes.
In the present study, as a marker for KNDy cells, we used kiss-
peptin immunoreactivity. Although the presence of KNDy cells has
been confirmed in various species (9,14), it must be noted that sin-
gle-labelled populations of NKB and/or kisspeptin cells have been
documented in male humans (15) and mice (12,51). Therefore, we
cannot exclude the possibility that we are overseeing potential
changes in the co-localisation of NK3R and NKB-only cells. How-
ever, because previous work has shown that prenatal testosterone
decreases NKB and dynorphin but not kisspeptin expression (33),
we chose kisspeptin as a marker for KNDy cells because this pep-
tide would not be affected by the treatment itself.
Although the above evidence supports a central role for NKB in
regulating GnRH secretion, this influence in the ewe was assumed
to be largely indirect, based on the complete absence of NK3R-IR
co-localisation in ovine GnRH cells (11). Instead, the stimulatory
influence of NKB in KNDy cells on GnRH secretion is considered to
be conveyed by kisspeptin as an output signal, acting upon either
GnRH cell bodies or terminals (13). Evidence for this upstream site
of action originates from studies in which kisspeptin antagonists
have been shown to block the stimulatory effects of NKB or senk-
tide (52), as well as studies in which desensitisation of the kiss-
peptin receptor blocks the stimulatory effect of senktide in
monkeys (53), and the absence of the stimulatory effect of senk-
tide in Kiss1r KO mice (54). The current working hypothesis of the
mechanisms by which NKB acts as a stimulatory ‘start’ signal in
the generation of GnRH pulses in the ewe posits this action occur-
ring via reciprocal KNDy-KNDy inputs at the level of KNDy cell
bodies. Our observation in the present study of NK3R-IR localisa-
tion in terminals that are presynaptic to GnRH cell bodies suggests
another possibility: NKB release by KNDy terminals acts in an aut-
oregulatory manner upon the same terminals contributing to the
enhanced release of kisspeptin. However, because we did not
co-localise NK3R with KNDy peptides in inputs contacting GnRH
neurones, we cannot conclude that the presynaptic NK3R inputs
that we observed arose from KNDy cells and, indeed, they may
have originated from any of the number of other NK3R-IR cell
populations. For example, the effects of senktide injections in the
POA on LH secretion (20) may be mediated either by actions on
NK3R-containing cell bodies in that region, or by presynaptic NK3R
in contact with POA GnRH neurones. Because we found very little
co-localisation (approximately 5%) of NK3R within kisspeptin cells
of the POA, it is possible that senktide effects on LH secretion
from injections into this area are independent of kisspeptin, and
are mediated instead by other transmitters/peptides. It is notewor-
thy that the effects of senktide on GnRH release in tissue slices of
the mouse median eminence are also independent of kisspeptin
(55) and because GnRH neurones in the mouse (12), similar to the
sheep (11), lack NK3R, it is possible that the effect of senktide in
the median eminence is also mediated by presynaptic actions of
NKB, in this case via axo-axonic contacts. The possibility of presyn-
aptic actions of NKB is supported by evidence in other systems
and species; for example, in the rat striatum, in which tachykinins
presynaptically stimulate the release of dopamine (56). Finally, we
would note that the observations reported in the present study are
based on control animals; the possibility that changes in presynap-
tic localisation of NK3R are present in prenatal testosterone female
sheep and contribute to reproductive neuroendocrine defects
remains to be examined.
In summary, the decreases in NK3R that we observed in the ARC
of prenatal testosterone-treated ewes complement previous obser-
vations of decreases in NKB and dynorphin peptides in KNDy cells
(33) and suggest that the combined reduction in ligand and recep-
tor components of NKB/NK3R signalling may contribute to altera-
tions in the control of pulsatile or surge modes of GnRH/LH
secretion. The constellation of adult reproductive dysfunction, as
well as metabolic defects, in prenatal testosterone-treated ewes is
very similar to that observed in women with polycystic ovarian syn-
drome (PCOS) (29) suggesting that the prenatal testosterone ewe
may serve as a model for this disease (28). KNDy cells are present
in the human female infundibular nucleus (equivalent to the ARC
in ewes) and show morphological changes with loss of steroid
feedback regulation of GnRH/LH (57,58). For example, in the infun-
dibular nucleus of postmenopausal women, NKB gene expression is
elevated as a result of reduced oestrogen negative-feedback (59).
Thus, we would speculate that alterations in NKB/NK3R signalling
may be, at least in part, responsible for the ovulatory defects
observed in patients with PCOS. The prenatal testosterone-treated
ewe could serve as an important translational model to test this
hypothesis, with regard to the feedback control of GnRH/LH pulses,
as well as the generation of the preovulatory LH surge.
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